DRTS News and Press, Alpha Tau Medical Ltd. From 12/09/25

- First patient in the world treated with Alpha DaRT ® in the brain – - According to the National Brain Tumor Society, glioblastoma is one of the most complex, deadly, and treatment-resistant cancers, with an estimated average survival rate of only 8 months –...

JERUSALEM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , announced today that two abstracts have been accepted to the 202...

JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot stu...

JERUSALEM, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced that CFO Raphi Levy will present in the following investo...

2025-11-20 16:13:56 ET More on Alpha Tau Medical Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology Seeking Alpha’s Quant Rating on Alpha Tau Medical Historical earnings data for Alpha Tau Medical Financial information for Alpha T...

- Alpha DaRT pancreatic cancer p atient treatments underway in U.S. multi-center pilot study - - Newly received r adioactive m aterial l icense for New Hampshire f acility positions the Company for continued advancement t owards ...

Home Depot Inc. (The) (HD) is expected to report $3.81 for Q3 2026 Euroseas Ltd. (ESEA) is expected to report $4.4 for Q3 2025 Kindly MD, Inc. (NAKA) is expected to report $-0.01 for Q3 2025 Gorilla Technology Group Inc. (GRRR) is expected to report $0.26 for Q3 2025 Golub Capital...

JERUSALEM, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced that CFO Raphi Levy will participate at the Jefferies Glo...

- Receipt of c ritical license marks significant milestone for f irst commercial-scale manufacturing facility for Alpha DaRT ® , the innovative alpha-radiation cancer therapy designed for potent and conformal tumor irradiation - - L icense paves wa...

2025-10-16 11:55:45 ET Intro Alpha Tau Medical ( DRTS ) is pioneering the first and (as far as we are aware) only way of delivering alpha particle radiation locally to solid tumors. While the company is not currently well known, this represents a potentially significant breakthrough...